Elizabeth Sanders, DPM
Podiatrist · Boston, MANPI 1962822452
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,337 of the $8,053 with a category attached, or 66.3%. 11 manufacturers reported payments, led by Arthrex at 27.9% of the total. Among podiatrist clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $151.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Kairos Surgical Inc$2K
- Smith+Nephew$1K
- Orthofix Medical, Inc.$1K
- Trimed, Inc.$500
- Linvatec Corporation$284
- plus $567 from 5 others
What the payments were for
- Travel & lodging$5,33766%
- Food & beverage$1,51619%
- Education$1,20015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $2,244 |
| Kairos Surgical Inc | 8 | $1,764 |
| Smith+Nephew | 5 | $1,469 |
| Orthofix Medical, Inc. | 9 | $1,224 |
| Trimed, Inc. | 1 | $500 |
| Linvatec Corporation | 4 | $284 |
| Stryker | 2 | $211 |
| Integra Lifesciences Corporation | 3 | $202 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $100 |
| Kerecis Limited | 1 | $48 |
| Reprise Biomedical, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,053 in reported general payments places this provider in the 90th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 235 | $5,522 |
| Diclofenac Sodium | 72 | $3,709 |
| Clotrimazole | 71 | $2,009 |
| Ciclopirox | 38 | $1,447 |
| Clonidine | 11 | $1,083 |
| Econazole Nitrate | 24 | $890 |
| Oxycodone Hcl | 78 | $532 |
| Methylprednisolone | 11 | $108 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $77 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Boston
- Thanh DinhBoston$48K
- Barry RosenblumBoston$43K
- John GiuriniBoston$6K
- Daphne RobertBoston$5K
- Hau PhamBoston$5K
- Jennifer SkolnikBoston$4K
- Thomas LyonsBoston$2K
- Ashley DanielBoston$2K
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.